Company Search:
Advanced Search
Sponsored Links
Amgen Inc. Company Snapshot
Amgen Inc. operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Amgen Inc. with three other companies in this sector in UNITED STATES : Biogen Inc (2019 sales of $14.38 billion of which 100% was Biopharmaceutical), Gilead Sciences, Inc. ($22.45 billion of which 100% was discovery, development and commercializa), and Grifols SA ($5.70 billion of which 78% was Bioscience).

Sales Analysis. Amgen Inc. reported sales of $23.36 billion for the year ending December of 2019. This represents a decrease of 1.6% versus 2018, when the company's sales were $23.75 billion. Contributing to the drop in overall sales was the 68.9% decline in Sensipar, from $1.77 billion to $551.00 million. There were also decreases in sales in Neulasta (down 28.0% to $3.22 billion) and Aranesp (down 7.9% to $1.73 billion) and Other Revenues (down 4.6% to $1.16 billion) and Epogen (down 14.2% to $867.00 million) . However, these declines were partially offset by the increase in sales of Enbrel (up 4.2% to $5.23 billion) and Other Products (up 15.2% to $4.96 billion) and Prolia (up 16.6% to $2.67 billion) and Xgeva (up 8.3% to $1.94 billion) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Amgen Inc.
  Stock Performance Chart for Amgen Inc.
  Stock Data: Recent Stock Performance:
  Current Price (1/15/2021): 245.49
(Figures in U.S. Dollars)
1 Week 2.9%   13 Weeks 7.4%  
4 Weeks 4.1%   52 Weeks 1.7%  
Amgen Inc. Key Data:
  Ticker: AMGN Country: United States
  Exchanges: NAS FRA HKG MXK Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2019 Sales 23,362,000,000
(Year Ending Jan 2020).
Employees: 23,400
  Currency: U.S. Dollars Market Cap: 143,243,415,000
  Fiscal Yr Ends: December Shares Outstanding: 583,500,000
  Share Type: Common Closely Held Shares: 1,036,569
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.